clinical trial · NCT03678480
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
HighTide Therapeutics (Hong Kong) Limited·phase2·withdrawn
Primary Sclerosing CholangitisCholangitisCholangitis, SclerosingBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesAdolescentHTD1801Ursodeoxycholic Acid
brief summary
Randomized, double-blind, active-controlled, parallel-group study of HTD1801 in adolescents.
started
Mar 1, 2021
primary completion
Oct 4, 2021
completion
Nov 4, 2021
last updated
Aug 12, 2026
official title
A Phase 2, Randomized, Double-Blind Study of HTD1801 vs Ursodeoxycholic Acid (UDCA) in Adolescents With Primary Sclerosing Cholangitis (PSC)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol